dr. guru sonpavde
Published 5 years ago • 60 plays • Length 6:57Download video MP4
Download video MP3
Similar videos
-
2:01
dr. guru sonpavde, dana-farber cancer institute, usa
-
2:10
highlights in bladder cancer
-
1:44
dr. guru sonpavde on bladder cancer | dana-farber cancer institute
-
4:18
dr. guru sonpavde on nivolumab, gem-cis fda approval and role in treating metastatic bladder cancer
-
3:55
critical trial review in gu oncology, interview with guru sonpavde md
-
0:46
dr. sonpavde on the need for phase 3 data with pembrolizumab or atezolizumab in bladder cancer
-
3:35
immunotherapy treatments for kidney cancer
-
1:08
dr. sonpavde on ongoing trials with immunotherapy for penile cancer
-
1:17:35
delayed cancer care, a bigger problem than covid 19 - dr.s.srivatsan gurumurthy
-
24:46
treatment talk | explaining chemotherapy for bladder cancer
-
3:48
prostate patient: ron’s story
-
1:10
dr. sonpavde on the potential for neoadjuvant immunotherapy in bladder cancer
-
1:05
dr. sonpavde on the role of durvalumab in platinum-refractory bladder cancer
-
3:47
the implications of race in prostate cancer
-
21:59
treatment talk | what are germline mutations in bladder cancer?
-
1:24
dr. sonpavde on neoadjuvant immunotherapy in bladder cancer
-
0:50
dr. sonpavde on immunotherapy combination studies in urothelial carcinoma
-
0:53
dr. sonpavde on immunotherapy plus chemotherapy in bladder cancer
-
1:27
dr. sonpavde on enfortumab vedotin data in bladder cancer
-
1:43
dr. sonpavde discusses a study of fixed-dose durvalumab and tremelimumab in urothelial carcinoma
-
2:07
dana-farber cancer institute: guru sonpavde, md (bladder cancer research at asco gu21)
-
2:02
dana-farber cancer institute: guru sonpavde, md at asco gu21 (bladder cancer)